(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BUVIDAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BUVIDAL

ST13

US500000079253793

Class

10

Filing

79253793

Registration

5946883

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

08/11/2026

Trademark type

Word

Nice classes

10

Filing date

11/26/2018

Registration date

12/31/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/17/2026

Last transaction

08/11/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

SE

Examiner

KHAN, AHSEN M

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Camurus AB

Representatives

Karen Kreider Gaunt Dinsmore & Shohl LLP

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Devices for subcutaneous administration of drugs sold empty; injection devices for parenteral administration of drugs; injection devices for drug depot injection; injection devices for subcutaneous drug depot injection; injection devices for parenteral drug depot injection; injection devices for administration of solution for injection; injection devices for administration of drug depot injection; syringes for subcutaneous administration of drugs; syringes for parenteral administration of drugs; syringes for drug depot injection; syringes for subcutaneous drug depot injection; syringes for parenteral drug depot injection; syringes for administration of solutions for injection; syringes for administration of drug depot injection; syringes for injections; syringes for medical purposes; medical apparatus and instrumentsneedles for medical purposes

Publications

History of USPTO decisions and trademark events.

35 publications found

C71T

CANCELLED SECTION 71

07/17/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

03/14/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

12/31/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/04/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/04/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/04/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/04/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/04/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/04/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/24/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/01/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/13/2020

FIMP

FINAL DISPOSITION PROCESSED

04/13/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/31/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

12/31/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/15/2019

PUBO

PUBLISHED FOR OPPOSITION

10/15/2019

GPNX

NOTIFICATION PROCESSED BY IB

10/12/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/25/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/25/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/25/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/06/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/06/2019

ALIE

ASSIGNED TO LIE

09/03/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/27/2019

RFNT

REFUSAL PROCESSED BY IB

04/06/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/20/2019

RFRR

REFUSAL PROCESSED BY MPU

03/20/2019

MAFR

APPLICATION FILING RECEIPT MAILED

03/16/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/15/2019

CNRT

NON-FINAL ACTION WRITTEN

03/14/2019

DOCK

ASSIGNED TO EXAMINER

03/12/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/12/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/07/2019

Continuous trademark protection

Get notified about every new filing that threatens BUVIDAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.